Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency

Summary

Patients with congestive heart failure, grade 3-4, in addition to the standard care, will be randomized 1:1. The study group will receive 2 doses of IV iron (Iron carboxymaltose). The control group will receive standard of care alone. The study will test for the effects of the additional IV iron on the symptoms, clinical picture and quality of life of the treated patients.

Timeline

Start

2016-12-14

Primary completion

2018-02-06

Completion

2018-02-06

Drugs

Indications